TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia - Yahoo! Finance
Links shared publicly online about this topic.
- 42total visits
TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia - Yahoo! Finance
From Yahoo! Finance: Tonix Pharmaceuticals Holding Corp. , a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system completed a pharmacokinetic study of the first formulation of its lead drug, TNX-102, for the treatment of fibromyalgia syndrome .
View full resource at finance.yahoo.com
Most Recently Shared on April 6, 2012 at 2:01 am By:
TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia: Tonix Phar... http://t.co/pdPV40RY
Advertisement
